Citadel Advisors - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,256,879
-10.2%
130,517
-0.8%
0.00%
Q2 2023$1,400,085
-65.3%
131,587
-65.7%
0.00%
-100.0%
Q1 2023$4,040,321
+221.4%
384,061
+278.5%
0.00%
Q4 2022$1,257,263
+554.8%
101,474
+447.9%
0.00%
Q3 2022$192,000
-98.2%
18,519
-97.8%
0.00%
-100.0%
Q1 2022$10,829,000
+116.8%
860,848
+100.9%
0.00%
+100.0%
Q4 2021$4,996,000
+105.5%
428,527
+130.2%
0.00%
Q3 2021$2,431,000
-41.1%
186,134
-42.0%
0.00%
Q2 2021$4,129,000
-15.1%
320,835
-26.3%
0.00%
-100.0%
Q1 2021$4,865,000
+11.2%
435,074
+13.3%
0.00%0.0%
Q4 2020$4,375,000
-25.3%
384,143
-41.0%
0.00%
-50.0%
Q3 2020$5,858,000
-24.0%
651,246
-12.8%
0.00%
-33.3%
Q2 2020$7,710,000
+0.4%
747,047
-1.9%
0.00%0.0%
Q1 2020$7,682,000
-57.0%
761,327
-43.3%
0.00%
-62.5%
Q4 2019$17,867,000
-19.3%
1,342,365
-47.9%
0.01%
-20.0%
Q3 2019$22,134,000
-51.3%
2,578,169
-37.9%
0.01%
-52.4%
Q2 2019$45,418,000
+0.1%
4,151,562
+23.8%
0.02%
-4.5%
Q1 2019$45,358,000
+183.5%
3,352,438
+117.1%
0.02%
+175.0%
Q4 2018$15,998,000
+74.4%
1,544,085
+210.8%
0.01%
+100.0%
Q3 2018$9,172,000
-14.2%
496,833
-11.1%
0.00%
-20.0%
Q2 2018$10,687,000
+165.2%
558,918
+114.0%
0.01%
+150.0%
Q1 2018$4,030,000
+2568.9%
261,195
+2486.1%
0.00%
Q4 2017$151,000
-38.9%
10,100
-22.9%
0.00%
Q2 2017$247,000
-93.1%
13,100
-94.2%
0.00%
-100.0%
Q3 2016$3,557,000
+2574.4%
223,997
+2097.3%
0.00%
Q2 2016$133,000
-96.1%
10,194
-96.9%
0.00%
-100.0%
Q3 2015$3,391,000
-29.3%
325,483
+8.6%
0.00%
-40.0%
Q1 2015$4,793,000
+492.5%
299,582
+467.5%
0.01%
+400.0%
Q4 2014$809,000
-72.0%
52,792
-76.3%
0.00%
-66.7%
Q3 2014$2,887,000
+527.6%
222,892
+642.7%
0.00%
+200.0%
Q2 2014$460,000
-42.7%
30,010
-53.9%
0.00%0.0%
Q1 2014$803,000
-81.2%
65,135
-82.3%
0.00%
-83.3%
Q4 2013$4,276,000
+191.3%
368,278
+197.3%
0.01%
+200.0%
Q3 2013$1,468,000
+17.7%
123,878
-1.1%
0.00%0.0%
Q2 2013$1,247,000125,3160.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders